Photo: Yahoo
Artificial intelligence has been hailed as a revolutionary force across industries, from finance to healthcare. But according to Thomas Wolf, co-founder of $4.5 billion AI startup Hugging Face, today’s leading AI systems are unlikely to make groundbreaking scientific discoveries on their own.
Wolf argues that current AI tools — including widely known chatbots like ChatGPT — are built to predict the most probable next word or token in a sequence. While this makes them powerful assistants for tasks like summarizing research or analyzing data, it fundamentally limits their ability to produce the kind of contrarian, paradigm-shifting insights that define Nobel Prize–level science.
Wolf highlights a key distinction between scientists and machines: the human drive to challenge consensus. Throughout history, transformative discoveries have come from individuals willing to think against the grain.
Take Nicolaus Copernicus, who upended centuries of belief by proposing that the Earth revolved around the sun. Such insights often seem improbable — even absurd — at first. AI, by contrast, is trained to align with human inputs and reinforce what is already known. When users prompt a chatbot, it often echoes agreement, praising the question rather than pushing back or suggesting a radical alternative.
“The scientist is not trying to predict the most likely next word,” Wolf explained. “He’s trying to predict this very novel thing that’s surprisingly unlikely — but true.”
Wolf’s stance contrasts sharply with more optimistic voices in the AI community. Sam Altman, CEO of OpenAI, and Dario Amodei, co-founder of Anthropic, have both suggested that AI could compress decades of scientific progress into just a few years.
Amodei has even argued that AI-enabled biology and medicine could accelerate human progress by a factor of ten, pushing forward advances that would have otherwise taken a century. This vision of AI as a catalyst for rapid breakthroughs is one that Wolf remains skeptical of, at least with current-generation models.
Instead of displacing scientists, Wolf believes AI is better positioned to serve as an intelligent assistant. These tools can help researchers analyze data, identify patterns, and explore directions they may not have considered.
This approach is already yielding results. Google DeepMind’s AlphaFold has mapped millions of protein structures, a feat that could dramatically speed up drug discovery and treatment development. While not a “breakthrough” in the Copernican sense, it represents how AI can augment scientific work by removing barriers and accelerating existing research.
Despite Wolf’s skepticism, a wave of startups is aiming to push AI beyond the role of co-pilot. Companies like Lila Sciences and FutureHouse are experimenting with systems designed not just to assist, but to hypothesize and generate new scientific ideas.
If successful, these ventures could begin to close the gap between predictive AI and truly creative discovery. For now, however, AI remains a tool for amplifying human intelligence rather than replacing it in the pursuit of scientific revolutions.
While the hype around AI often paints it as an all-powerful disruptor, Wolf’s perspective underscores the importance of grounding expectations. Current models excel at pattern recognition, data analysis, and knowledge synthesis, but they lack the contrarian spark that has historically fueled humanity’s greatest scientific achievements.
The future may bring more advanced systems capable of generating novel insights, but for now, AI’s most valuable role is in partnership with human scientists — not in replacing them.